We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differentia... Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists. Show more
CARLSBAD, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter ended June 30, 2024...
Just one session following the company releasing strong Q1 2024 earnings, a California-based healthcare company is finding tremendous success on Tuesday. This comes as no real To read the full...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2 | 10.3092783505 | 1.94 | 2.05 | 1.85 | 38333 | 1.98245659 | CS |
4 | 0.26 | 13.829787234 | 1.88 | 2.21 | 1.71 | 26283 | 1.9737557 | CS |
12 | 0.76 | 55.0724637681 | 1.38 | 2.21 | 1.35 | 40712 | 1.86124991 | CS |
26 | 0.21 | 10.8808290155 | 1.93 | 2.4 | 1.3003 | 37936 | 1.82373402 | CS |
52 | -0.33 | -13.3603238866 | 2.47 | 2.9499 | 1.3003 | 35684 | 1.8659213 | CS |
156 | -10.87 | -83.5511145273 | 13.01 | 14.9 | 1.3003 | 41574 | 5.28126929 | CS |
260 | -14.66 | -87.2619047619 | 16.8 | 29.858 | 1.3003 | 45891 | 10.43089941 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions